Clinical trials
Withdrawn Overweight trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 4 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 25 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Columbia University | 1 |
| Dompé Farmaceutici S.p.A | 1 |
| Eli Lilly and Company | 1 |
| Emory University | 1 |
| Florida State University | 1 |
| Jean L. Fry | 1 |
| Kansas State University | 1 |
| Medical College of Wisconsin | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
| Novo Nordisk A/S | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 25 |
| Obesity | 22 |
| Weight Loss | 5 |
| Insulin Resistance | 4 |
| Prediabetic State | 3 |
| Body Weight | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Hypertension | 2 |
| Obesity, Morbid | 2 |
| Attention Deficit Disorder with Hyperactivity | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.